WAM
PALI icon

Warberg Asset Management’s Palisade Bio PALI Stock Holding History

Warberg Asset Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-667
Closed -$5.9K – 234
2023
Q4 		$5.9K Hold
667
– – ﹤0.01% 181
2023
Q3 		$5.82K Buy
+667
New +$12.2K ﹤0.01% 196
2023
Q1 		– Sell
-1,754
Closed -$137K – 275
2022
Q4 		$137K Buy
1,754
+1,554
+777% +$90.1K 0.02% 129
2022
Q3 		$15K Buy
+200
New +$42.3K ﹤0.01% 216

Other funds holding PALI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Warberg Asset Management's PALI Position: Q1 2024 in Review

Warberg Asset Management sold out of Palisade Bio (PALI) in Q1 2024, closing a stake of 667 shares — an estimated $5.9K sold.

Warberg Asset Management first reported a position in PALI in Q3 2022 and held it in 4 quarters. The position peaked at $137K in Q4 2022. 15 funds tracked by Wall St. Rank hold PALI as of Q1 2024.

  • Warberg Asset Management reported no remaining Palisade Bio position as of Q1 2024 after selling out during the quarter.
  • Warberg Asset Management sold 667 Palisade Bio shares in Q1 2024, an estimated $5.9K.
  • Warberg Asset Management first reported a position in Palisade Bio in Q3 2022 and held it in 4 quarters.
  • Warberg Asset Management's Palisade Bio position peaked at $137K in Q4 2022.
  • 15 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2024.

Based on Warberg Asset Management's 13F filing for Q1 2024, filed 6 May 2024.